Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Search results for "drug treatment"
Home
Celltrion Secures Japanese Approval for Xolair and Eylea Biosimilars
Celltrion announced on the 27th that it has obtained marketing authorization from Japan’s Ministry of Health, Labour and Welfare for two key...
03/30/2026, 02:30 ET
“We Can’t Afford Dad's Medicine”: The Heartbreaking Reality of Late-Stage Cancer Costs
“Should we sell the house? Dad’s medication is just too expensive.”This is the agonizing question keeping a mother in her 60s and a daughter in her...
03/30/2026, 02:17 ET
Korea’s 40th New Drug ‘Nuviju’ Launches: A Three-Way Battle for the Double-Chin Market
Medytox is set to shake up the aesthetic medicine industry with the launch of "Nuviju," a new treatment for submental...
03/24/2026, 04:19 ET
Oscotec to Present Kidney Failure Treatment Candidate at World Congress of Nephrology in Japan
Oscotec announced on the 23rd that it will present animal-model proof-of-concept results for a new drug candidate...
03/24/2026, 02:47 ET
HK inno.N’s ‘Ecnoglutide’: Can a Late Entrant’s “Hidden Card” Reshape the Obesity Market?
HK inno.N is fast-tracking the South Korean launch of ecnoglutide, a GLP-1 receptor agonist licensed from China’s...
03/23/2026, 02:59 ET
Benign Prostatic Hyperplasia Medication Linked to 52% Higher Risk of Acute Glaucoma
A large-scale study in South Korea has revealed that alpha-blockers—the most common treatment for benign prostatic...
03/23/2026, 02:59 ET
A Single Cancer Shot: Local Injection Triggers Systemic Tumor Disappearance
For decades, one immuno-oncology strategy has held immense promise while repeatedly falling short: the use of CD40...
03/23/2026, 02:58 ET
Why Breast Cancer Patients Should Get Brain MRIs Even Without Symptoms
Study results suggest that some breast cancer patients should receive regular brain MRI (magnetic resonance imaging)...
03/18/2026, 03:08 ET
Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation
Idience, a novel anticancer drug developer under the Ildong Pharmaceutical Group, announced on the 18th that its...
03/18/2026, 03:08 ET
6 out of 10 Diet Pill Users Say They Take It to Lose Weight Even Though They Are Not Obese
About 60% of those taking medication to suppress appetite are reported to not be obese.
03/17/2026, 02:04 ET
Previous
11
12
13
14
15
Next
Languages
ENGLISH
English (US)
ASIAN
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية